Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Angiotensin Ii. Always confirm against the full prescribing information.
8 interactions
Chloroprocaine
The risk or severity of adverse effects can be increased when Angiotensin II is combined with Chloroprocaine.
Level 1 evidence
Lidocaine
The risk or severity of hypertension can be increased when Angiotensin II is combined with Lidocaine.
Level 1 evidence
Oxytocin
The risk or severity of hypertension can be increased when Angiotensin II is combined with Oxytocin.
Level 1 evidence
Landiolol
The therapeutic efficacy of Landiolol can be decreased when used in combination with Angiotensin II.
Level 1 evidence
Levothyroxine
Levothyroxine may increase the vasoconstricting activities of Angiotensin II.
Level 2 evidence
Liothyronine
Liothyronine may increase the vasoconstricting activities of Angiotensin II.
Level 2 evidence
Thyroid, porcine
Thyroid, porcine may increase the vasoconstricting activities of Angiotensin II.
Level 2 evidence
Thyrotropin alfa
Thyrotropin alfa may increase the vasoconstricting activities of Angiotensin II.
Angiotensin Ii has 8 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Angiotensin Ii has 0 major, 3 moderate, and 5 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Angiotensin Ii. Always confirm against the full prescribing information.